Validation and Predictive Power of Radiation Therapy Oncology Group (RTOG) Recursive Partitioning Analysis Classes for Malignant Glioma Patients: A Report Using RTOG 90-06☆-Reference-Cited by-同舟云学术

Validation and Predictive Power of Radiation Therapy Oncology Group (RTOG) Recursive Partitioning Analysis Classes for Malignant Glioma Patients: A Report Using RTOG 90-06☆

Published:1998-01-01 Issue:1 Volume:40 Page:51-55
ISSN:0360-3016
Container-title:International Journal of Radiation OncologyBiologyPhysics
language:en
Short-container-title:International Journal of Radiation OncologyBiologyPhysics

Author:

Scott Ph.D. Charles B,Scarantino M.D., Ph.D., Charles,Urtasun M.D., Raul,Movsas M.D., Benjamin,Jones M.D., Christopher U,Simpson M.D., Joseph R,Fischbach M.D., A.Jennifer,Curran Jr., M.D. Walter J

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Cited by 290 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radio-chemotherapy feasibility for biopsy-only unresectable IDH wild-type glioblastomas (BO-GBM);Neuro-Oncology Practice;2023-05-30

2. Imaging of GBM in the Age of Molecular Markers and MRI Guided Adaptive Radiation Therapy;Journal of Clinical Medicine;2022-10-10

3. Investigation of histological heterogeneity based on the discrepancy between the hyperintense area on T2-weighted images and the accumulation area on 11C-methionine PET in minimally enhancing glioma;Interdisciplinary Neurosurgery;2022-03

4. High grade gliomas;Progress in Brain Research;2022

5. Malignant glioma subset from actuate 1801: Phase I/II study of 9-ING-41, GSK-3β inhibitor, monotherapy or combined with chemotherapy for refractory malignancies;Neuro-Oncology Advances;2022-01-01